Ascorbic acid in contrast-induced nephropathy
Phase 3
Recruiting
- Conditions
- Acute coronary syndrome.Acute coronary thrombosis not resulting in myocardial infarction
- Registration Number
- IRCT20151109024975N7
- Lead Sponsor
- Mazandaran University of Medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
patients undergoing angiography and contrast media
Contrast nephropathy score above 5
Age between 18-85
Exclusion Criteria
End stage Renal disease patients
Contrast usage 1 week before and 72 hours after study
Coadministration of nephrotoxic drug
Vitamin C usage during last 1 week
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ephropathy. Timepoint: 5 days. Method of measurement: creatine.
- Secondary Outcome Measures
Name Time Method ????????. Timepoint: 1 week. Method of measurement: creatine.;Dialysis. Timepoint: 10 days. Method of measurement: Creatinin.;Mortality. Timepoint: 2 weeks. Method of measurement: patients follow up.